Instrumentation Metrics Inc.
This article was originally published in Start Up
Executive SummaryInstrumentation Metrics is a four-year-old diagnostics startup which is focusing on non-invasive point of care diagnostics instrument. As its first test, the young company is targeting glucose monitoring for diabetes. Start-ups in this field have a miserable track record of success, but IM's founder and CEO, Steve Malin, thinks IM's approach is dfferent.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.